Skip to main content
British Medical Journal logoLink to British Medical Journal
editorial
. 1978 Sep 23;2(6141):845–846.

Poliomyelitis vaccines: killed or live?

PMCID: PMC1607955  PMID: 709087

Full text

PDF
845

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bijkerk H., Draaisma F. J., Landheer T., van Os M. Poliomyelitisepidemie in Staphorst. Ned Tijdschr Geneeskd. 1972 Apr 1;116(14):549–558. [PubMed] [Google Scholar]
  2. Dömök I., Balayan M. S., Fayinka O. A., Skrtić N., Soneji A. D., Harland P. S. Factors affecting the efficacy of live poliovirus vaccine in warm climates. Efficacy of type 1 Sabin vaccine administered together with antihuman gamma-globulin horse serum to breast-fed and artificially fed infants in Uganda. Bull World Health Organ. 1974;51(4):333–347. [PMC free article] [PubMed] [Google Scholar]
  3. Ofosu-Amaah S., Kratzer J. H., Nicholas D. D. Is poliomyelitis a serious problem in developing countries?--lameness in Ghanaian schools. Br Med J. 1977 Apr 16;1(6067):1012–1014. doi: 10.1136/bmj.1.6067.1012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Reid D., Yetts R., Oddy C. G., Benson P. F. Poliomyelitis antibody titres in children and effect of live and inactivated poliovaccine. Lancet. 1969 Mar 15;1(7594):564–566. doi: 10.1016/s0140-6736(69)91970-9. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES